# Echinacea Angustifolia (AnxioCalm) in Anxiety

> **NCT03463018** · PHASE2 · TERMINATED · sponsor: **EuroPharma, Inc.** · enrollment: 100 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** Echinacea angustifolia
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03463018
- **Lead sponsor:** EuroPharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-06
- **Primary completion:** 2020-10-03
- **Final completion:** 2021-12-15
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** Recruitment error; Inclusion criteria not met
- **Last updated:** 2022-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03463018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03463018, "Echinacea Angustifolia (AnxioCalm) in Anxiety". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03463018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*